Growth Metrics

Kraig Biocraft Laboratories (KBLB) Accumulated Depreciation & Amortization (2018 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Accumulated Depreciation & Amortization for 3 consecutive years, with -$82246.0 as the latest value for Q3 2022.

  • Quarterly Accumulated Depreciation & Amortization fell 7489.58% to -$82246.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was -$82246.0 through Sep 2022, down 7489.58% year-over-year, with the annual reading at $7947.0 for FY2021, N/A changed from the prior year.
  • Accumulated Depreciation & Amortization hit -$82246.0 in Q3 2022 for Kraig Biocraft Laboratories, up from -$88962.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $15397.0 in Q1 2022 to a low of -$88962.0 in Q2 2022.
  • Historically, Accumulated Depreciation & Amortization has averaged -$37569.8 across 3 years, with a median of -$39244.0 in 2018.
  • Biggest YoY gain for Accumulated Depreciation & Amortization was 120.44% in 2022; the steepest drop was 7489.58% in 2022.
  • Year by year, Accumulated Depreciation & Amortization stood at -$39372.0 in 2018, then skyrocketed by 120.18% to $7947.0 in 2021, then tumbled by 1134.93% to -$82246.0 in 2022.
  • Business Quant data shows Accumulated Depreciation & Amortization for KBLB at -$82246.0 in Q3 2022, -$88962.0 in Q2 2022, and $15397.0 in Q1 2022.